XML 65 R51.htm IDEA: XBRL DOCUMENT v3.24.0.1
Employee Incentive Plans (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Common Stock Reserved for Future Issuance
Shares of common stock reserved for future issuance was as follows:
December 31,20232022
Available for future RSU, PBRSU and stock option grants22,732,012 17,473,925 
Unvested RSUs, PBRSUs and stock options outstanding9,338,246 11,676,962 
Available for ESPP7,484,043 6,302,187 
Total reserved for future issuance39,554,301 35,453,074 
Total Stock-based Compensation Expense
Stock-based compensation expense, included in “Compensation and benefits” expense on the Income Statement, was as follows for the periods presented:
Year Ended December 31,202320222021
RSUs and PBRSUs$61,619 $74,334 $70,935 
Stock options— 46 599 
Stock-based compensation expense, gross61,619 74,380 71,534 
Less: Capitalized stock-based compensation expense
9,230 8,018 4,383 
Stock-based compensation expense, net
$52,389 $66,362 $67,151 
Schedule of RSU Activity
The following table summarizes the activities for the Company’s RSUs:
Number
of Units		Weighted-
Average
Grant Date
Fair Value
Unvested at December 31, 2022
8,672,626 $12.94 
Granted7,138,085 $7.57 
Vested(5,575,341)$11.44 
Forfeited/expired(3,235,539)$11.28 
Unvested at December 31, 2023
6,999,831 $9.42 
Schedule of PBRSU Activity
The following table summarizes the activities for the Company’s PBRSUs:
Number
of Units		Weighted-
Average
Grant Date
Fair Value
Unvested at December 31, 2022
1,754,898 $11.19 
Granted807,499 $7.15 
Vested(870,766)$4.22 
Forfeited/expired(221,818)$12.37 
Unvested at December 31, 2023
1,469,813 $12.60 
Schedule of Options Activity
The following table summarizes the activities for the Company’s stock options:
Number of
Options		Weighted-Average
Exercise
Price Per
Share		Weighted-Average
Remaining
Contractual Life (in years)
Aggregate
Intrinsic 
Value (1)
(in thousands)
Outstanding at December 31, 2022
1,249,451 $37.11 
Exercised
(35,473)$5.30 
Forfeited/Expired
(345,376)$35.57 
Outstanding at December 31, 2023
868,602 $39.02 1.2$15 
Exercisable at December 31, 2023
868,602 $39.02 1.2$15 
(1)    The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the Company’s closing stock price of $8.74 as reported on the New York Stock Exchange on December 29, 2023.